Transfusion-related risks associated with intraoperative immunoadsorption compared to plasma exchange transfusion in neonatal patients undergoing ABO-incompatible heart transplantation

Authors

Abstract

The aim of the proposed pilot study is to evaluate the transfusion-related risks associated with intraoperative immunoadsorption compared to PET in neonatal patients who undergo ABO-incompatible heart transplantation. Congenital heart defects (CHDs) are present in an average of 40,000 births per year in the United States, accounting for almost 1% of total births per year.

Recommended by Brian Hyndman. 

Downloads

Additional Files

Published

2021-10-12

How to Cite

Cole, S. (2021). Transfusion-related risks associated with intraoperative immunoadsorption compared to plasma exchange transfusion in neonatal patients undergoing ABO-incompatible heart transplantation . MICH: The Student Journal of the Michener Institute of Education, 3(1). Retrieved from https://journals.publicknowledgeproject.org/michener-student/index.php/michener-student/article/view/931

Issue

Vol. 3 No. 1 (2021): MICH: Volume 3

Section

Articles

License

Copyright (c) 2021 Sienna Cole

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a condition of publication in MICH all authors agree to the following terms of licensing/copyright ownership:

  • First publication rights to original work accepted for publication is granted to MICH but copyright for all work published in the journal is retained by the author(s).
  • Works published in MICH will be distributed under a Creative Commons Attribution License (CC-BY 4.0)
  •  Authors grant permission for their work to be indexed in full text form in commercial indexes.
  • Authors may enter into separate, additional contractual agreements for the non-exclusive distribution of the published version of the work, with an acknowledgement of its initial publication in MICH
  • It will be the responsibility of the authors to secure all necessary copyright permissions for the use of 3rd-party materials in their manuscript. Authors will be required to provide written evidence of this permission upon acceptance of their manuscript.